Capricor Therapeutics, Inc. (CAPR)
8.95
+0.01
(+0.11%)
USD |
NASDAQ |
Oct 02, 16:00
9.02
+0.07
(+0.78%)
After-Hours: 20:00
Capricor Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | -63.94% |
| September 30, 2024 | -555.2% |
| June 30, 2024 | -277.0% |
| March 31, 2024 | -199.6% |
| December 31, 2023 | -6.30% |
| September 30, 2023 | -103.3% |
| June 30, 2023 | -188.0% |
| March 31, 2023 | -260.1% |
| December 31, 2022 | -804.3% |
| September 30, 2022 | -400.3% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | -2.33K% |
| March 31, 2021 | -12.63K% |
| December 31, 2020 | -7.23K% |
| September 30, 2020 | -23.14K% |
| June 30, 2020 | -6.98K% |
| March 31, 2020 | -1.12K% |
| December 31, 2019 | -661.6% |
| September 30, 2019 | -1.13K% |
| June 30, 2019 | -498.7% |
| March 31, 2019 | -1.93K% |
| December 31, 2018 | -503.0% |
| Date | Value |
|---|---|
| September 30, 2018 | -1.89K% |
| June 30, 2018 | -1.02K% |
| March 31, 2018 | -917.6% |
| December 31, 2017 | |
| September 30, 2017 | -873.0% |
| June 30, 2017 | -348.4% |
| March 31, 2017 | -416.3% |
| December 31, 2016 | -660.9% |
| September 30, 2016 | -780.2% |
| June 30, 2016 | -514.4% |
| March 31, 2016 | -468.1% |
| December 31, 2015 | -367.1% |
| September 30, 2015 | -319.5% |
| June 30, 2015 | -342.6% |
| March 31, 2015 | -194.4% |
| December 31, 2014 | -185.1% |
| September 30, 2014 | -148.2% |
| June 30, 2014 | -147.2% |
| March 31, 2014 | -116.2% |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | -185.2% |
| SELLAS Life Sciences Group, Inc. | -- |
| Sionna Therapeutics, Inc. | -- |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Cytokinetics, Inc. | -694.4% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -63.47% |
| Return on Assets | -49.21% |
| Return on Invested Capital | -55.21% |
| Return on Net Operating Assets | -278.2% |